You are here: Industry Insights > Sputnik V

News List

Dr Reddy’s receives EUA for Sputnik V in India expresspharma
April 14, 2021
Sputnik V uses two different vectors for the two shots in a course of vaccination and its efficacy was determined to be 91.6 per cent as per a published article in the Lancet.
SEC of CDSCO recommends approval to Sputnik V for EUA in India expresspharma
April 13, 2021
The DCGI will take a final call on the recommendation. If approved, it will be the third COVID-19 vaccine to be available in India.
Manufacture of Indian vaccine in Russia cannot be ruled out: Russian Foreign Minister expresspharma
April 08, 2021
The RDIF has signed contracts with several Indian contractors to manufacture the Sputnik V vaccine to the tune of 700-750 million doses.
RDIF and Panacea Biotec partner to produce 100 mn doses of Sputnik V vaccine in India annually expresspharma
April 06, 2021
The Russian Direct Investment Fund (RDIF) and Panacea Biotec announce cooperation to produce 100 million doses per year of Sputnik V.
DCGI approval for Sputnik V vaccine expected in next few weeks: Dr Reddy’s official expresspharma
March 30, 2021
Dr Reddy’s Laboratories expects the Russian coronavirus vaccine Sputnik V to get approval from the Indian regulator in the next few weeks, a company official has said.
Brazil could approve Russian coronavirus vaccine in days, says pharmaceutical firm expresspharma
March 25, 2021
The Brazilian pharmaceutical company that plans to produce Russia’s coronavirus vaccine Sputnik V said on Tuesday it expects to overcome regulatory obstacles in “two or three” days to obtain authorisation to make and sell the shot in Brazil.
RDIF, Virchow Biotech sign agreement to produce 200 million doses of Sputnik V vaccine expresspharma
March 23, 2021
The technology transfer is expected to be completed in the second quarter of 2021 followed by full-scale commercial production of Sputnik V.
RDIF, Stelis Biopharma join hands for 200 mn doses of Sputnik V vaccine expresspharma
March 22, 2021
The Russian Direct Investment Fund (RDIF), and Stelis Biopharma, the biopharma division of Strides, have partnered to produce, and supply a minimum of 200 million doses of the Russian Sputnik V vaccine against coronavirus sufficient to vaccinate 100 ...
Philippines gives approval to Sputnik V Covid-19 vaccine for emergency use pharmaceutical-technology
March 19, 2021
The Food and Drug Administration of the Philippines has given approval to Sputnik V Covid-19 vaccine for emergency use, as the country struggles with spike in infections.
Gland Pharma signs deal with RDIF for 252 million Sputnik V vaccine doses expresspharma
March 17, 2021
Gland Pharma has signed a deal with the Russian Direct Investment Fund (RDIF) to make up to 252 million doses of the Sputnik V COVID-19 vaccine, bringing India’s total production of the shot to at least 352 million.

Previous page 1 2 3 4 5 6 7 8 Next page